{"transactions":[{"id":774953,"issuer":{"id":46432,"kind":"organization","name":"SOLENO THERAPEUTICS INC","symbol":"SLNO"},"owners":[{"id":46437,"kind":"person","name":"Norrett Kevin","position":1,"cik":"0001819690","reported_name":"Norrett Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (Right to buy)","published_at":"2026-05-18T20:42:51.000Z","date":"2026-05-18","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":4000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"At the effective time of the Merger, this option was cancelled in exchange for a cash payment equal to (x) the difference between the Merger Consideration and the per share exercise price of the option, multiplied by (y) the number of shares covered by the option as of immediately prior to such cancellation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"At the effective time of the Merger, this option was cancelled in exchange for a cash payment equal to (x) the difference between the Merger Consideration and the per share exercise price of the option, multiplied by (y) the number of shares covered by the option as of immediately prior to such cancellation."}],"balance_after":0,"derivative":{"exercise_price":43.65,"expiration_date":"2036-01-21","underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001819690-26-000004","document":"form4-05182026_080545.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1484565/000181969026000004/form4-05182026_080545.xml","form_type":"4"}},{"id":774952,"issuer":{"id":46432,"kind":"organization","name":"SOLENO THERAPEUTICS INC","symbol":"SLNO"},"owners":[{"id":46437,"kind":"person","name":"Norrett Kevin","position":1,"cik":"0001819690","reported_name":"Norrett Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (Right to buy)","published_at":"2026-05-18T20:42:51.000Z","date":"2026-05-18","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":64286,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"At the effective time of the Merger, this option was cancelled in exchange for a cash payment equal to (x) the difference between the Merger Consideration and the per share exercise price of the option, multiplied by (y) the number of shares covered by the option as of immediately prior to such cancellation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"At the effective time of the Merger, this option was cancelled in exchange for a cash payment equal to (x) the difference between the Merger Consideration and the per share exercise price of the option, multiplied by (y) the number of shares covered by the option as of immediately prior to such cancellation."}],"balance_after":0,"derivative":{"exercise_price":47.25,"expiration_date":"2035-11-17","underlying":"Common Stock","underlying_shares":64286},"source":{"system":"sec-edgar","filing":"0001819690-26-000004","document":"form4-05182026_080545.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1484565/000181969026000004/form4-05182026_080545.xml","form_type":"4"}},{"id":774951,"issuer":{"id":46432,"kind":"organization","name":"SOLENO THERAPEUTICS INC","symbol":"SLNO"},"owners":[{"id":46437,"kind":"person","name":"Norrett Kevin","position":1,"cik":"0001819690","reported_name":"Norrett Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2026-05-18T20:42:51.000Z","date":"2026-05-18","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":17786,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares are represented by previously reported restricted stock units (\"RSUs\"). Pursuant to the Agreement and Plan of Merger, dated as of April 5, 2026, by and among Soleno Therapeutics, Inc. (the \"Company\"), Neocrine Biosciences, Inc. (\"Parent\") and Sigma Merger Sub, Inc. (\"Merger Sub\"), on May 18, 2026, Merger Sub merged with and into the Company (the \"Merger\"), with the Company continuing as the surviving corporation and a wholly owned subsidiary of Parent. In connection with the Merger, each issued and outstanding vested and unvested RSU was cancelled and converted into the right to receive an amount equal to $53.00 in cash (the \"Merger Consideration\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In connection with the Merger, each issued and outstanding share of the Company's Common Stock was cancelled and converted into the right to receive an amount in cash equal to the Merger Consideration."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001819690-26-000004","document":"form4-05182026_080545.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1484565/000181969026000004/form4-05182026_080545.xml","form_type":"4"}},{"id":932250,"issuer":{"id":46432,"kind":"organization","name":"SOLENO THERAPEUTICS INC","symbol":"SLNO"},"owners":[{"id":46437,"kind":"person","name":"Norrett Kevin","position":1,"cik":"0001819690","reported_name":"Norrett Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Employee stock option (right to buy)","published_at":"2026-01-23T23:07:08.000Z","date":"2026-01-21","kind":"grant","planned":false,"acquired":true,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/48th of the shares subject to the option shall vest on February 1, 2026 and each one-month anniversary thereafter, subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2014 Equity Incentive Plan) through each such date."}],"balance_after":4000,"derivative":{"exercise_price":43.65,"expiration_date":"2036-01-21","underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001819690-26-000002","document":"form4-01232026_110102.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1484565/000181969026000002/form4-01232026_110102.xml","form_type":"4"}},{"id":932249,"issuer":{"id":46432,"kind":"organization","name":"SOLENO THERAPEUTICS INC","symbol":"SLNO"},"owners":[{"id":46437,"kind":"person","name":"Norrett Kevin","position":1,"cik":"0001819690","reported_name":"Norrett Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2026-01-23T23:07:08.000Z","date":"2026-01-21","kind":"grant","planned":false,"acquired":true,"shares":3500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These securities are restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of Common Stock. 100% of the RSUs shall vest on December 15, 2027, subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2014 Equity Incentive Plan) through such date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These securities are RSUs. Each RSU represents a contingent right to receive one share of Common Stock, subject to the applicable vesting schedule and conditions of each RSU."}],"balance_after":17786,"source":{"system":"sec-edgar","filing":"0001819690-26-000002","document":"form4-01232026_110102.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1484565/000181969026000002/form4-01232026_110102.xml","form_type":"4"}},{"id":993802,"issuer":{"id":46432,"kind":"organization","name":"SOLENO THERAPEUTICS INC","symbol":"SLNO"},"owners":[{"id":46437,"kind":"person","name":"Norrett Kevin","position":1,"cik":"0001819690","reported_name":"Norrett Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Employee stock option (right to buy)","published_at":"2025-11-19T23:49:51.000Z","date":"2025-11-17","kind":"exercise","planned":false,"acquired":true,"shares":64286,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-fourth of the shares subject to the option shall vest on November 17, 2026 and one forty-eighth of the shares subject to the option shall vest each month thereafter on the same day of the month, subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2014 Equity Incentive Plan) through each such date."}],"balance_after":64286,"derivative":{"exercise_price":47.25,"expiration_date":"2035-11-17","underlying":"Common Stock","underlying_shares":64286},"source":{"system":"sec-edgar","filing":"0001819690-25-000008","document":"form4-11192025_111147.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1484565/000181969025000008/form4-11192025_111147.xml","form_type":"4"}},{"id":993801,"issuer":{"id":46432,"kind":"organization","name":"SOLENO THERAPEUTICS INC","symbol":"SLNO"},"owners":[{"id":46437,"kind":"person","name":"Norrett Kevin","position":1,"cik":"0001819690","reported_name":"Norrett Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2025-11-19T23:49:51.000Z","date":"2025-11-17","kind":"grant","planned":false,"acquired":true,"shares":14286,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These securities are restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of Common Stock. One-half of the RSUs shall vest on November 17, 2026 and one third of the remaining RSUs shall vest each one-year anniversary thereafter, subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2014 Equity Incentive Plan) through each such date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These securities are restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of Common Stock. One-half of the RSUs shall vest on November 17, 2026 and one third of the remaining RSUs shall vest each one-year anniversary thereafter, subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2014 Equity Incentive Plan) through each such date."}],"balance_after":14286,"source":{"system":"sec-edgar","filing":"0001819690-25-000008","document":"form4-11192025_111147.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1484565/000181969025000008/form4-11192025_111147.xml","form_type":"4"}},{"id":1278548,"issuer":{"id":6428,"kind":"organization","name":"CODEXIS, INC.","symbol":"CDXS"},"owners":[{"id":46437,"kind":"person","name":"Norrett Kevin","position":1,"cik":"0001819690","reported_name":"Norrett Kevin","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-08T01:20:55.000Z","date":"2025-02-05","kind":"grant","planned":false,"acquired":true,"shares":161250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests and becomes exercisable with respect to 25% of the shares subject thereto on the first anniversary of the grant date, and with respect to 1/48th of the original number of shares subject thereto on each monthly anniversary thereafter, subject to the Reporting Person's continued employment through the applicable vesting dates."}],"balance_after":161250,"derivative":{"exercise_price":4.37,"expiration_date":"2035-02-05","underlying":"Common Stock","underlying_shares":161250},"source":{"system":"sec-edgar","filing":"0000905148-25-000444","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1200375/000090514825000444/form4.xml","form_type":"4"}},{"id":1278547,"issuer":{"id":6428,"kind":"organization","name":"CODEXIS, INC.","symbol":"CDXS"},"owners":[{"id":46437,"kind":"person","name":"Norrett Kevin","position":1,"cik":"0001819690","reported_name":"Norrett Kevin","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2025-02-08T01:20:55.000Z","date":"2025-02-05","kind":"grant","planned":false,"acquired":true,"shares":26875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units vest as to 1/3rd of the shares on each annual anniversary of the grant date, subject to the Reporting Person's continued employment through the applicable vesting dates."}],"balance_after":177327,"source":{"system":"sec-edgar","filing":"0000905148-25-000444","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1200375/000090514825000444/form4.xml","form_type":"4"}},{"id":1696225,"issuer":{"id":6428,"kind":"organization","name":"CODEXIS, INC.","symbol":"CDXS"},"owners":[{"id":46437,"kind":"person","name":"Norrett Kevin","position":1,"cik":"0001819690","reported_name":"Norrett Kevin","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-03T02:24:10.000Z","date":"2024-01-01","kind":"grant","planned":false,"acquired":true,"shares":314125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests and becomes exercisable with respect to 1/3rd of the shares subject thereto on the first anniversary of the grant date, and with respect to 1/36th of the original number of shares subject thereto on each monthly anniversary thereafter, subject to the Reporting Person's continued employment through the applicable vesting dates."}],"balance_after":314125,"derivative":{"exercise_price":3.05,"expiration_date":"2034-01-01","underlying":"Common Stock","underlying_shares":314125},"source":{"system":"sec-edgar","filing":"0000905148-24-000031","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1200375/000090514824000031/form4.xml","form_type":"4"}},{"id":1696224,"issuer":{"id":6428,"kind":"organization","name":"CODEXIS, INC.","symbol":"CDXS"},"owners":[{"id":46437,"kind":"person","name":"Norrett Kevin","position":1,"cik":"0001819690","reported_name":"Norrett Kevin","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2024-01-03T02:24:10.000Z","date":"2024-01-01","kind":"grant","planned":false,"acquired":true,"shares":52350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units vest as to 1/3rd of the shares on each annual anniversary of the grant date, subject to the Reporting Person's continued employment through the applicable vesting dates."}],"balance_after":150452,"source":{"system":"sec-edgar","filing":"0000905148-24-000031","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1200375/000090514824000031/form4.xml","form_type":"4"}},{"id":1782779,"issuer":{"id":6428,"kind":"organization","name":"CODEXIS, INC.","symbol":"CDXS"},"owners":[{"id":46437,"kind":"person","name":"Norrett Kevin","position":1,"cik":"0001819690","reported_name":"Norrett Kevin","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-09-12T20:07:21.000Z","date":"2023-09-11","kind":"purchase","planned":false,"acquired":true,"shares":9000,"price":1.7199,"value":15479.1,"ownership":{"direct":true},"balance_after":98102,"source":{"system":"sec-edgar","filing":"0000905148-23-000902","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1200375/000090514823000902/form4.xml","form_type":"4"}},{"id":1960735,"issuer":{"id":6428,"kind":"organization","name":"CODEXIS, INC.","symbol":"CDXS"},"owners":[{"id":46437,"kind":"person","name":"Norrett Kevin","position":1,"cik":"0001819690","reported_name":"Norrett Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-03-10T02:16:03.000Z","date":"2023-03-08","kind":"sale","acquired":false,"shares":8258,"price":4.5552,"value":37616.8416,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares were sold solely to satisfy tax or other government withholding obligations in connection with the vesting of shares subject to a PSUs of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects the weighted average of all shares sold to cover taxes upon vesting of PSUs on March 8, 2023 for certain employees of the Issuer."}],"balance_after":89102,"source":{"system":"sec-edgar","filing":"0001567619-23-004773","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1200375/000156761923004773/doc1.xml","form_type":"4"}},{"id":1960734,"issuer":{"id":6428,"kind":"organization","name":"CODEXIS, INC.","symbol":"CDXS"},"owners":[{"id":46437,"kind":"person","name":"Norrett Kevin","position":1,"cik":"0001819690","reported_name":"Norrett Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-03-10T02:16:03.000Z","date":"2023-03-07","kind":"sale","acquired":false,"shares":8596,"price":4.6027,"value":39564.8092,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares were sold solely to satisfy tax or other government withholding obligations in connection with the vesting of shares subject to a PSUs of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects the weighted average of all shares sold to cover taxes upon vesting of PSUs on March 8, 2023 for certain employees of the Issuer."}],"balance_after":97360,"source":{"system":"sec-edgar","filing":"0001567619-23-004773","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1200375/000156761923004773/doc1.xml","form_type":"4"}},{"id":1960733,"issuer":{"id":6428,"kind":"organization","name":"CODEXIS, INC.","symbol":"CDXS"},"owners":[{"id":46437,"kind":"person","name":"Norrett Kevin","position":1,"cik":"0001819690","reported_name":"Norrett Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-03-10T02:16:03.000Z","date":"2023-02-08","kind":"grant","acquired":true,"shares":83456,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock awards (\"PSUs\") initially granted on November 8, 2022 that were subject a performance-based vesting condition. The vesting condition was determined to be 85% satisfied on February 8, 2023. The PSUs will vest fully on March 5, 2024, subject to the Reporting Person's continued service to the Issuer on such vesting date."}],"balance_after":105956,"source":{"system":"sec-edgar","filing":"0001567619-23-004773","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1200375/000156761923004773/doc1.xml","form_type":"4"}},{"id":2003128,"issuer":{"id":6428,"kind":"organization","name":"CODEXIS, INC.","symbol":"CDXS"},"owners":[{"id":46437,"kind":"person","name":"Norrett Kevin","position":1,"cik":"0001819690","reported_name":"Norrett Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-22T01:28:11.000Z","date":"2023-02-21","kind":"grant","acquired":true,"shares":67500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Option vests and becomes exercisable with respect to 25% of the shares subject thereto on February 21, 2024, with 1/48th of the shares vesting monthly thereafter, such that the option will be fully vested and exercisable on February 21, 2027, in each case, subject to continued service through the applicable vesting date."}],"balance_after":67500,"derivative":{"exercise_price":5.44,"expiration_date":"2033-02-21","underlying":"Common Stock","underlying_shares":67500},"source":{"system":"sec-edgar","filing":"0001567619-23-003443","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1200375/000156761923003443/doc1.xml","form_type":"4"}},{"id":2003127,"issuer":{"id":6428,"kind":"organization","name":"CODEXIS, INC.","symbol":"CDXS"},"owners":[{"id":46437,"kind":"person","name":"Norrett Kevin","position":1,"cik":"0001819690","reported_name":"Norrett Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-02-22T01:28:11.000Z","date":"2023-02-21","kind":"grant","acquired":true,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted Stock Units (\"RSUs\") vest 1/3 annually from February 21, 2023 such that the RSUs will be fully vested on February 21, 2026. Each RSU represents a contingent right to receive one share of Codexis common stock."}],"balance_after":22500,"source":{"system":"sec-edgar","filing":"0001567619-23-003443","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1200375/000156761923003443/doc1.xml","form_type":"4"}},{"id":2142027,"issuer":{"id":6428,"kind":"organization","name":"CODEXIS, INC.","symbol":"CDXS"},"owners":[{"id":46437,"kind":"person","name":"Norrett Kevin","position":1,"cik":"0001819690","reported_name":"Norrett Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-10-05T20:17:36.000Z","date":"2022-10-03","kind":"grant","acquired":true,"shares":413405,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests and becomes exercisable with respect to 25% of the shares subject thereto on October 3, 2023, with 1/48th of the shares vesting monthly thereafter, such that the option will be fully vested and exercisable on October 3, 2026, in each case, subject to continued service through the applicable vesting date."}],"balance_after":413405,"derivative":{"exercise_price":6.07,"expiration_date":"2032-10-03","underlying":"Common Stock","underlying_shares":413405},"source":{"system":"sec-edgar","filing":"0001567619-22-018272","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1200375/000156761922018272/doc1.xml","form_type":"4"}},{"id":2216961,"issuer":{"id":125698,"kind":"organization","name":"Sierra Oncology, Inc.","symbol":"SRRA"},"owners":[{"id":46437,"kind":"person","name":"Norrett Kevin","position":1,"cik":"0001819690","reported_name":"Norrett Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-07-01T16:28:58.000Z","date":"2022-07-01","kind":"disposition_to_issuer","acquired":false,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the merger agreement between issuer, GlaxoSmithKline plc (\"GSK\") and a subsidiary of GSK, this option was cancelled on the effective date of the merger in exchange for a cash payment equal to, on a per share basis, the offer price of $55.00 less the exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option vests as to 25% of the total shares subject to the option on March 14, 2023, and then 2.0833% of the shares subject to the option vest monthly thereafter, with 100% of the total shares subject to the option vested on March 14, 2026, subject to Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":0,"derivative":{"exercise_price":31.54,"expiration_date":"2032-03-14","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001209191-22-040236","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1290149/000120919122040236/doc4.xml","form_type":"4"}},{"id":2216960,"issuer":{"id":125698,"kind":"organization","name":"Sierra Oncology, Inc.","symbol":"SRRA"},"owners":[{"id":46437,"kind":"person","name":"Norrett Kevin","position":1,"cik":"0001819690","reported_name":"Norrett Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-07-01T16:28:58.000Z","date":"2022-07-01","kind":"disposition_to_issuer","acquired":false,"shares":11700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the merger agreement between issuer, GlaxoSmithKline plc (\"GSK\") and a subsidiary of GSK, this option was cancelled on the effective date of the merger in exchange for a cash payment equal to, on a per share basis, the offer price of $55.00 less the exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vested as to 25% of the total shares subject to the option on March 15, 2022, and then 2.0833% of the shares subject to the option vest monthly thereafter, with 100% of the total shares subject to the option vested on March 15, 2025, subject to Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":0,"derivative":{"exercise_price":16.73,"expiration_date":"2031-03-15","underlying":"Common Stock","underlying_shares":11700},"source":{"system":"sec-edgar","filing":"0001209191-22-040236","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1290149/000120919122040236/doc4.xml","form_type":"4"}},{"id":2216959,"issuer":{"id":125698,"kind":"organization","name":"Sierra Oncology, Inc.","symbol":"SRRA"},"owners":[{"id":46437,"kind":"person","name":"Norrett Kevin","position":1,"cik":"0001819690","reported_name":"Norrett Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-07-01T16:28:58.000Z","date":"2022-07-01","kind":"disposition_to_issuer","acquired":false,"shares":49000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the merger agreement between issuer, GlaxoSmithKline plc (\"GSK\") and a subsidiary of GSK, this option was cancelled on the effective date of the merger in exchange for a cash payment equal to, on a per share basis, the offer price of $55.00 less the exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On August 12, 2020, the Reporting Person was granted an option to purchase 49,000 shares of common stock. The option vests based on the satisfaction by Issuer of certain performance criteria."}],"balance_after":0,"derivative":{"exercise_price":12.15,"expiration_date":"2030-08-12","underlying":"Common Stock","underlying_shares":49000},"source":{"system":"sec-edgar","filing":"0001209191-22-040236","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1290149/000120919122040236/doc4.xml","form_type":"4"}},{"id":2216958,"issuer":{"id":125698,"kind":"organization","name":"Sierra Oncology, Inc.","symbol":"SRRA"},"owners":[{"id":46437,"kind":"person","name":"Norrett Kevin","position":1,"cik":"0001819690","reported_name":"Norrett Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-07-01T16:28:58.000Z","date":"2022-07-01","kind":"disposition_to_issuer","acquired":false,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the merger agreement between issuer, GlaxoSmithKline plc (\"GSK\") and a subsidiary of GSK, this option was cancelled on the effective date of the merger in exchange for a cash payment equal to, on a per share basis, the offer price of $55.00 less the exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vested as to 25% of the total shares on August 10, 2021, and then the remaining shares vest in equal monthly installments over the following 36 months, with 100% of the total shares vested on August 10, 2024, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":0,"derivative":{"exercise_price":12.05,"expiration_date":"2030-08-10","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001209191-22-040236","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1290149/000120919122040236/doc4.xml","form_type":"4"}},{"id":2227408,"issuer":{"id":125698,"kind":"organization","name":"Sierra Oncology, Inc.","symbol":"SRRA"},"owners":[{"id":46437,"kind":"person","name":"Norrett Kevin","position":1,"cik":"0001819690","reported_name":"Norrett Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-17T16:16:32.000Z","date":"2022-06-17","kind":"grant","acquired":true,"shares":12250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"On August 12, 2020, the reporting person was granted an option to purchase 49,000 shares of common stock. The option vests based on the satisfaction by Issuer of certain performance criteria. The achievement of one of the performance criteria resulted in vesting of the option as to 12,250 shares."}],"balance_after":12250,"derivative":{"exercise_price":12.15,"exercise_date":"2022-06-17","expiration_date":"2030-08-12","underlying":"Common Stock","underlying_shares":12250},"source":{"system":"sec-edgar","filing":"0001209191-22-037847","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1290149/000120919122037847/doc4.xml","form_type":"4"}},{"id":2335221,"issuer":{"id":125698,"kind":"organization","name":"Sierra Oncology, Inc.","symbol":"SRRA"},"owners":[{"id":46437,"kind":"person","name":"Norrett Kevin","position":1,"cik":"0001819690","reported_name":"Norrett Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-14T16:43:53.000Z","date":"2022-03-14","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 25% of the total shares subject to the option on March 14, 2023, and then 2.0833% of the shares subject to the option vest monthly\nthereafter, with 100% of the total shares subject to the option vested on March 14, 2026, subject to Reporting Person's provision of service to the Issuer on\neach vesting date."}],"balance_after":35000,"derivative":{"exercise_price":31.54,"expiration_date":"2032-03-14","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001209191-22-018486","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1290149/000120919122018486/doc4.xml","form_type":"4"}},{"id":2422352,"issuer":{"id":125698,"kind":"organization","name":"Sierra Oncology, Inc.","symbol":"SRRA"},"owners":[{"id":46437,"kind":"person","name":"Norrett Kevin","position":1,"cik":"0001819690","reported_name":"Norrett Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-28T18:33:35.000Z","date":"2022-01-28","kind":"grant","acquired":true,"shares":12250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"On August 12, 2020, the Reporting Person was granted an option to purchase 49,000 shares of common stock. The option vests based on the satisfaction by Issuer of certain performance criteria. The achievement of one of the performance criteria resulted in vesting of the option as to 12,250 shares."}],"balance_after":12250,"derivative":{"exercise_price":12.15,"exercise_date":"2022-01-28","expiration_date":"2030-08-12","underlying":"Common Stock","underlying_shares":12250},"source":{"system":"sec-edgar","filing":"0001209191-22-005483","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1290149/000120919122005483/doc4.xml","form_type":"4"}},{"id":2781670,"issuer":{"id":125698,"kind":"organization","name":"Sierra Oncology, Inc.","symbol":"SRRA"},"owners":[{"id":46437,"kind":"person","name":"Norrett Kevin","position":1,"cik":"0001819690","reported_name":"Norrett Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-17T21:17:17.000Z","date":"2021-03-15","kind":"grant","acquired":true,"shares":11700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 25% of the total shares subject to the option on March 15, 2022, and then 2.0833% of the shares subject to the option vest monthly thereafter, with 100% of the total shares subject to the option vested on March 15, 2025, subject to Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":11700,"derivative":{"exercise_price":16.73,"expiration_date":"2031-03-15","underlying":"Common Stock","underlying_shares":11700},"source":{"system":"sec-edgar","filing":"0001209191-21-021622","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1290149/000120919121021622/doc4.xml","form_type":"4"}},{"id":3061719,"issuer":{"id":125698,"kind":"organization","name":"Sierra Oncology, Inc.","symbol":"SRRA"},"owners":[{"id":46437,"kind":"person","name":"Norrett Kevin","position":1,"cik":"0001819690","reported_name":"Norrett Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock option (right to buy)","published_at":"2020-08-11T17:54:35.000Z","date":"2020-08-10","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 25% of the total shares on August 10, 2021, and then the remaining shares vest in equal monthly installments over the following 36 months, with 100% of the total shares vested on August 10, 2024, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":100000,"derivative":{"exercise_price":12.05,"expiration_date":"2030-08-10","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001209191-20-046213","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1290149/000120919120046213/doc4.xml","form_type":"4"}}]}